2001
DOI: 10.1002/1521-3773(20010618)40:12<2292::aid-anie2292>3.0.co;2-d
|View full text |Cite
|
Sign up to set email alerts
|

Chemoenzymatic-Chemical Synthesis of a (2-3)-Sialyl T Threonine Building Block and Its Application to the Synthesis of the N-Terminal Sequence of Leukemia-Associated Leukosialin (CD 43)

Abstract: Protection of all functional groups of the carbohydrate portion of the chemoenzymatically synthesized sialyl T threonine ester 1 (R=R1=H, R2=tBu, Fmoc=9‐fluorenylmethoxycarbonyl) and subsequent acidolysis of the tert‐butyl ester afforded the building block 2 (R=Ac, R1=Me, R2=H). The latter is a useful tool in the solid‐phase synthesis of the N‐terminal sequence 3 of the leukemia‐associated leukosialin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
23
0

Year Published

2003
2003
2022
2022

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 48 publications
(24 citation statements)
references
References 11 publications
1
23
0
Order By: Relevance
“…The advantage of using a chemoenzymatic approach is that enzymatically catalyzed reactions usually proceed with both high regio-and stereoselectivity and therefore, eliminates the need for complicated protecting group manipulations. The successful enzyme-catalyzed synthesis of a 2,3-sialyl-T building block [164,165] is a good example of such a chemoenzymatic approach. The T N derivative (12) was used as the acceptor in this procedure (Fig.…”
Section: Chemoenzymatic Synthesis [164165]supporting
confidence: 56%
See 1 more Smart Citation
“…The advantage of using a chemoenzymatic approach is that enzymatically catalyzed reactions usually proceed with both high regio-and stereoselectivity and therefore, eliminates the need for complicated protecting group manipulations. The successful enzyme-catalyzed synthesis of a 2,3-sialyl-T building block [164,165] is a good example of such a chemoenzymatic approach. The T N derivative (12) was used as the acceptor in this procedure (Fig.…”
Section: Chemoenzymatic Synthesis [164165]supporting
confidence: 56%
“…. Chemoenzymatic synthesis of 2,3-ST-building block[164,165]. (a) lactose, β-galactosidase (bovine testes), CMP-NeuNAc, α-2,3-sialyltransferase, alkaline phosphatase (calf instestine), 2,6-di-O-methyl-β-cyclodextrin, BSA, pH 6.5, 50% (b) 1.…”
mentioning
confidence: 99%
“…Next, the azido moiety of 8 was converted into an acetamido derivative by reaction with thioacetic acid in pyridine [33][34][35] and the resulting compound 9 was treated with a mixture of TFA and water to remove the t-butyl ester, and then with NaOMe in methanol to cleave the acetyl esters to give glycopeptide 10. 36 At this stage of the synthesis, the Cbz group was kept intact because protection of the amino group of serine is required for glycopeptide synthesis.…”
Section: Resultsmentioning
confidence: 99%
“…Tel: +81-463-50-2075; Fax: +81-463-50-2012; E-mail: yonak@keyaki.cc.u-tokai.ac.jp or hojo@keyaki.cc.u-tokai.ac.jp Abbreviations: BSA, bovine serum albumin; CMP-sialic acid, cytidine 5 0 -(5-acetamido-3,5-dideoxy-D-glycero--D-galacto-non-2-ulopyranosylonic acid monophosphate); DIEA, N,N-diisopropylethylamine; DMS, dimethylsulfide; Fmoc, 9-fluorenylmethoxycarbonyl; HBTU, O-benzotriazol-1-yl-N,N,N 0 ,N 0 -tetramethyluronium hexafluorophosphate; HOBt, 1-hydroxybenzotriazole; MS, mass spectrometry; MAb, monoclonal antibody; NMP, 1-methyl-2-pyrolidinone; Pbf, 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl; SPPS, solid-phase peptide synthesis; TFA, trifluoroacetic acid;TF-, -linked Thomsen-Friedenreich antigen; TfOH, trifluoromethanesulfonic acid; Trt, triphenylmethyl corresponding natural -trisaccharide has previously been synthesized by a fully chemical or chemoenzymatic method to use as building blocks for the solidphase synthesis of sialoglycopeptides by this group 7,8) and by others. 16,17) On the other hand, the related disaccharide, -D-Gal-(1!3)--D-GalNAc-Ser/Thr (TF-), had been synthesized by us to use in the epitope analysis of the colon carcinoma specific MAb, BW494, exhibiting cross-reactivity with -D-Gal-(1!3)--DGlcNAc (type 1 chain) and TF-. 18) In respect of the MUC1 glycopeptides carrying natural O-glycans, several groups have reported their synthetic efforts.…”
Section: -13)mentioning
confidence: 69%